PharmaCyte Biotech Inc (PMCB)

[Daphnis]

In regards to PMCB’s clinical hold by the FDA:

People who have been part of a new and innovative creative process that has significant weight know how difficult it is to simplify something that is very complicated and then explain it in the simplest way possible while covering every angle. This applies to every step they take and i am not surprised if they had to stop, take a step back and regroup along the way.

PMCB has been and is a creative process. I imagine unknowns have continued to pop up on their end even after each update and each milestone.
EVEN at the very end of this long process when the FDA and outside advisors gave feedback and an outline leading up to the submission of their ind - it would not of been without unknowns - so PMCB submitted what it viewed would lead to an FDA approval.

From what i have seen, the FDA should of let them begin trials while they address their requests given that a high percentage of patients die from pancreatic cancer. The FDA’s requests wont discredit the information they submitted. In my opinion the FDA is being overly cautious.

There is a risk for sure. We dont know everything going on behind the scenes.

This stock should not be this low even with the risk.
I have over 16 million shares with no regrets.